Fight Aging! Newsletter, June 5th 2017
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more. This content is published under the Creative Commons Attribution 3.0 license. You are encouraged to republish and rewrite it in any way you see fit, the only requirements being that you provide attribution and a link to Fight Aging! To subscribe or unsubscribe please visit: https://www.fightaging.org/newsletter/ Contents Reviewing the Measurement of Biological Age in Humans The Degree to which Vascular Stiffness and Hypertension are Secondary Aging MicroRNA Inhibition to Enhance Skin Healing A High Level View of the State of SENS Rejuvenation Research An Angiogenesis Hypothesis of Aging Latest Headlines from Fight Aging! Modifying Macrophages to Accelerate Healing An Interview with James Peyer of Apollo Ventures A Potential Target to Prevent One Class of Autoimmune Diseases Impaired Insulin Signaling Outside the Nervous System Fail...
Publication date: Available online 10 July 2020Source: International Review of NeurobiologyAuthor(s): Russell H. Swerdlow
Publication date: Available online 10 July 2020Source: International Review of NeurobiologyAuthor(s): Mark P. Mattson
Publication date: Available online 10 July 2020Source: Clinica Chimica ActaAuthor(s): Zhisheng Huang, Zhuoru He, Yu Kong, Zhongqiu Liu, Lingzhi Gong
Publication date: Available online 10 July 2020Source: Clinica Chimica ActaAuthor(s): Xingzhong Hu, Dong Chen, Lianpeng Wu, Guiqing He, Wei Ye
Publication date: Available online 9 July 2020Source: Obesity Research &Clinical PracticeAuthor(s): Abdulzahra Hussain, Kamal Mahawar, Zefeng Xia, Wah Yang, Shamsi EL-Hasani
In this study, we investigated the antitumor activity of H2Mab-19 in an LN229 glioblastoma xenograft model. H2Mab-19 showed high binding affinity (KD: 1.1 × 10-8 M) against LN229 cells. Furthermore, H2Mab-19 significantly reduced tumor development in an LN229 xenograft. These results suggest that treatment with H2Mab-19 may be a useful therapy for patients with HER2-expressing glioblastomas. PMID: 32644843 [PubMed - as supplied by publisher]
CONCLUSIONS Our results revealed that SNHG15 alleviated OA progression by regulating ECM homeostasis, which provides a promising target for OA therapy. PMID: 32643707 [PubMed - in process]
Publication date: Available online 10 July 2020Source: Food ChemistryAuthor(s): Ting Xia, Wenhui Duan, Zhujun Zhang, Bin Fang, Bo Zhang, Bicheng Xu, Celia Bertha Vargas de la Cruz, Hesham El-Seedi, Jesus Simal-Gandara, Shaoyun Wang, Min Wang, Jianbo Xiao
Publication date: Available online 9 July 2020Source: Food BioscienceAuthor(s): Hai-long Zhang, Qing-xiao Wu, Xiao Wei, Xiao-ming Qin
AbstractTo evaluate the efficacy and safety of holmium laser enucleation of prostate (HoLEP) for treating urinary retention in patients with advanced prostate cancer. Thirty-eight cases of advanced prostate cancer with urinary retention were enrolled in this retrospective study. All the 38 patients were treated with CAB as a basis. Among them, 21 cases chose HoLEP additionally (HoLEP group). Seventeen cases stuck to CAB alone (CAB group). Serum PSA level, International Prostate Symptom Score (IPSS), quality of life score (QoLs), maximal flow rate (Qmax), and post-void residual volume (PVR) at 3, 6, 12, and 18 months after ...
More News: Academia | Alzheimer's | Amyloidosis | Arthritis | Atrial Fibrillation | Autoimmune Disease | Biochemistry | Biology | Biotechnology | Blindness | Brain | Brain Cancers | Budgets | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Chemistry | Cholesterol | Clinical Trials | Conferences | Databases & Libraries | Dementia | Diabetes | Diabetes Mellitus | Disability | Drugs & Pharmacology | Eating Disorders & Weight Management | Endocrinology | Environmental Health | Epidemiology | Fortamet | Funding | Fundraising | Gastroschisis Repair | Gene Therapy | Genetics | Geriatrics | Heart | Heart Attack | Heart Disease | Hormones | Hypertension | Infectious Diseases | Insulin | Internet | Ischemic Stroke | Keloids | Laboratory Medicine | Learning | Liver | Men | Metformin | Mitochondria | Mitochondrial Disease | Molecular Biology | Myocarditis | Nanotechnology | Neurology | Neuroscience | Nutrition | Obesity | Opthalmology | Orthopaedics | Osteoarthritis | Pancreas | Pancreatic Cancer | Parkinson's Disease | Pathology | Perinatology & Neonatology | Peripheral Vascular Disease (PVD) | Pharmaceuticals | Physiology | Research | Rheumatology | Science | Skin | Sports Medicine | Stem Cell Therapy | Stem Cells | Stroke | Study | Toxicology | Universities & Medical Training | Urology & Nephrology | Vitamins | Yale